These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6169957)

  • 61. Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.
    Weidmann P; De Chătel R; Ziegler WH; Flammer J; Reubi F
    Am J Cardiol; 1978 Mar; 41(3):570-6. PubMed ID: 343564
    [No Abstract]   [Full Text] [Related]  

  • 62. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
    Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Labetalol in the preoperative management of phaeochromocytoma.
    Russell WJ; Kaines AH; Hooper MJ; Frewin DB
    Anaesth Intensive Care; 1982 May; 10(2):160-3. PubMed ID: 6125109
    [No Abstract]   [Full Text] [Related]  

  • 65. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
    Miano L; Kolloch R; De Quattro V
    Clin Chim Acta; 1979 Jul; 95(2):211-7. PubMed ID: 527220
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.
    Smith WB; Clifton GG; O'Neill WM; Wallin JD
    Hypertension; 1983; 5(4):579-83. PubMed ID: 6862581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
    Lardoux H; Gerard J; Blazquez G; Chouty F; Flouvat B
    Eur Heart J; 1983 Nov; 4 Suppl G():35-40. PubMed ID: 6662119
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Chamberlain DA
    Eur Heart J; 1980 Dec; 1(6):413-6. PubMed ID: 7274255
    [No Abstract]   [Full Text] [Related]  

  • 69. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics].
    Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A
    Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536
    [No Abstract]   [Full Text] [Related]  

  • 71. [Clinical application of adrenoceptor blockers in the treatment of hypertension].
    Mikami H; Ogihara T
    Nihon Rinsho; 1989 Sep; 47(9):2035-40. PubMed ID: 2574242
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo.
    Maharaj RJ; Thompson M; Brock-Utne JG; Williamson R; Downing JW
    S Afr Med J; 1983 Apr; 63(18):691-4. PubMed ID: 6342168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Labetalol and 24-hour monitoring of arterial blood pressure in hypertensive patients.
    Ferrari A; Buccino N; Di Rienzo M; Pedotti A; Mancia G; Zanchetti A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S42-52. PubMed ID: 6169959
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.
    Halprin S; Frishman W; Kirschner M; Strom J
    Am Heart J; 1980 Mar; 99(3):388-96. PubMed ID: 7355700
    [No Abstract]   [Full Text] [Related]  

  • 75. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P; Pessina AC; Sperti G; Ventura E; Agnoletto V; Semplicini A; Hlede M; Gava R; Mormino P; Dal Palù C
    G Ital Cardiol; 1983; 13(1):18-22. PubMed ID: 6873535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Protective effect of alpha beta-blockers on hypertensive target-organ damage].
    Kai H; Imaizumi T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():587-90. PubMed ID: 15171441
    [No Abstract]   [Full Text] [Related]  

  • 78. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Labetalol in resistant hypertension].
    Stern N; Teicher A; Rosenthal T
    Harefuah; 1981 Aug; 101(3-4):54-6. PubMed ID: 7319385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.